Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation

Blood

Volumn 115, Issue 15, 2010, Pages 3158-3161

  Villalobos, Itzel Bustos ^a   Takahashi, Yoshiyuki ^a   Akatsuka, Yoshiki ^b,c   Muramatsu, Hideki ^a   Nishio, Nobuhiro ^a   Hama, Asahito ^a   Yagasaki, Hiroshi ^a   Saji, Hiroh ^d   Kato, Motohiro ^e   Ogawa, Seishi ^e   Kojima, Seiji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c Fujita Healthy University   (Japan)

^d Academia for Repro Regenerative Medicine   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GENOMIC DNA;

ACUTE LEUKEMIA; ALLELE; ARTICLE; CANCER RELAPSE; CHROMOSOME 6; CHROMOSOME ARM; CLINICAL ARTICLE; CRYOPRESERVATION; DNA ISOLATION; DONOR LYMPHOCYTE INFUSION; FLOW CYTOMETRY; HAPLOIDY; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOSITY LOSS; HLA SYSTEM; HUMAN; IMMUNOSURVEILLANCE; LEUKEMIA CELL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNIPARENTAL DISOMY;

EID: 77951083382     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-254284     Document Type: Article

References (21)

1. Garrido F, Ruiz-Cabello F, Cabrera T, et al. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol Today. 1997;18(2):89-95. (Pubitemid 27107103)
2. Seliger B, Cabrera T, Garrido F, Ferrone S. HLA class I antigen abnormalities and immune escape by malignant cells. Semin Cancer Biol. 2002;12(1):3-13. (Pubitemid 34087893)
3. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol. 2000;74:181-273.
4. Wetzler M, Baer MR, Stewart SJ, et al. HLA class I antigen cell surface expression is preserved on acute myeloid leukemia blasts at diagnosis and at relapse. Leukemia. 2001;15(1):128-133. (Pubitemid 32124077)
5. Masuda K, Hiraki A, Fujii N, et al. Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts. Cancer Sci. 2007;98(1):102-108. (Pubitemid 44803927)
6. Takahashi Y, McCoy JP Jr, Carvallo C, et al. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood. 2004;103(4):1383-1390. (Pubitemid 38168653)
7. Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor: Japan Marrow Donor Program. N Engl J Med. 1998;339(17):1177-1185. (Pubitemid 28482126)
8. Nannya Y, Sanada M, Nakazaki K, et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 2005;65(14):6071-6079. (Pubitemid 40994391)
9. Torikai H, Akatsuka Y, Miyazaki M, et al. A novel HLA-A*3303- restricted minor histocompatibility antigen encoded by an unconventional open reading frame of human TMSB4Y gene. J Immunol. 2004;173(11):7046-7054. (Pubitemid 39541094)
10. Akatsuka Y, Nishida T, Kondo E, et al. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens. J Exp Med. 2003;197(11):1489-1500. (Pubitemid 36682546)
11. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods. 1990;128(2):189-201.
12. Kondo E, Topp MS, Kiem HP, et al. Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells. J Immunol. 2002;169(4):2164-2171. (Pubitemid 34857684)
13. Takahashi Y, Harashima N, Kajigaya S, et al. Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest. 2008;118(3):1099- 1109. (Pubitemid 351364617)
14. Tuna M, Knuutila S, Mills GB. Uniparental disomy in cancer. Trends Mol Med. 2009;15(3):120-128.
15. Koh LP, Rizzieri DA, Chao NJ. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. Biol Blood Marrow Transplant. 2007;13(11):1249-1267. (Pubitemid 47571038)
16. Vago L, Perna SK, Zanussi M, et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med. 2009;361(5):478-488.
17. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol. 2002;3(11):999-1005.
18. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
19. Velardi A, Ruggeri L, Mancusi A, et al. Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. Semin Immunopathol. 2008;30(4):489-503.
20. Kolb HJ. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood. 2008;112(12):4371-4383.
21. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica. 2007;92(3):414-417. (Pubitemid 350143554)